This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Estee Lauder Companies (EL) Online Business Aids Growth
by Zacks Equity Research
The Estee Lauder Companies' (EL) online operations and Skin Care business bode well. The company's solid presence in emerging markets is noteworthy.
The Estee Lauder Companies' (EL) Latest Move Aids Travel Retail
by Zacks Equity Research
The Estee Lauder Companies (EL) opens a 300,000 square feet state-of-the-art distribution center in Galgenen dedicated to its global Travel Retail business.
The Estee Lauder Companies' (EL) Skin Care Sales Aids Growth
by Zacks Equity Research
The Estee Lauder Companies' (EL) Skin Care portfolio has been performing well for a while now. It is benefiting from strong presence in emerging markets.
The Zacks Analyst Blog Highlights Accenture, SAP, The Estee Lauder, CME Group, and Aon
by Zacks Equity Research
Accenture, SAP, The Estee Lauder, CME Group, and Aon are part of Zacks top Analyst Blog.
Top Analyst Reports for Accenture, SAP & The Estee Lauder
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Accenture plc (ACN), SAP SE (SAP), and The Estee Lauder Companies Inc. (EL).
Nu Skin (NUS) Up 8.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Estee Lauder (EL) Down 2.7% Since Last Earnings Report?
by Zacks Equity Research
Estee Lauder (EL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Clorox (CLX) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Elevated manufacturing and logistics costs might have hurt Clorox's (CLX) bottom line in third-quarter fiscal 2022. Nonetheless, its IGNITE strategy appears encouraging.
The Estee Lauder Companies (EL) Beats on Earnings in Q3
by Zacks Equity Research
The Estee Lauder Companies' (EL) third-quarter fiscal 2022 sales and earnings rise year over year on growth in every product category. Management lowered fiscal 2022 view.
Fed's Crucial FOMC Meeting in Focus
by Zacks Equity Research
Fed's Crucial FOMC Meeting in Focus.
Amid a Big Week for the U.S. Economy, PFE, BP, EL Report
by Mark Vickery
Ahead of today's opening bell, we're in the green again, but only dipping a toe in the water just yet.
Estee Lauder (EL) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 14.46% and 1.81%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Clorox (CLX) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Elevated manufacturing and logistics costs might have hurt Clorox's (CLX) bottom line in third-quarter fiscal 2022. Nonetheless, its IGNITE strategy appears encouraging.
What's in Store for The Estee Lauder Companies' (EL) Q3 Earnings?
by Zacks Equity Research
The Estee Lauder Companies (EL) third-quarter fiscal 2022 performance will likely reflect solid Skin Care sales. Also, growth in online business has been a driver.
Here's How Colgate (CL) is Poised Just Before Q1 Earnings
by Zacks Equity Research
Colgate's (CL) Q1 results are expected to reflect gains from strong consumer demand, innovation and expansion plans amid supply-chain disruptions, and rising raw material and logistics costs.
Estee Lauder (EL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Estee Lauder (EL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hershey (HSY) Queued for Q1 Earnings: Things to Consider
by Zacks Equity Research
Hershey's (HSY) first-quarter 2022 performance is likely to reflect gains from prudent acquisitions and strategic pricing efforts.
What's in the Offing for Church & Dwight (CHD) in Q1 Earnings?
by Zacks Equity Research
Church & Dwight's (CHD) first-quarter results are likely to reflect gains from pricing, product innovation, buyouts and demand for certain categories, while high costs are a concern.
The Estee Lauder Companies' (EL) Online Sales Bode Well
by Zacks Equity Research
The Estee Lauder Companies (EL) is benefiting from a strong e-commerce business. Also, the company's Skin Care portfolio has been performing well.
Why the Earnings Surprise Streak Could Continue for Estee Lauder (EL)
by Zacks Equity Research
Estee Lauder (EL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Estee Lauder Companies (EL) Benefits From Skin Care Sales
by Zacks Equity Research
Estee Lauder (EL) is implementing new technology and digital experiences to boost online sales. Also, strength in the Skin Care category is driving growth.
Zacks Market Edge Highlights: Alphabet, Intuitive Surgical, The Estee Lauder Companies and Costco
by Zacks Equity Research
Alphabet, Intuitive Surgical, The Estee Lauder Companies and Costco are highlighted in this Market Edge article.
How to Find Lottery Stocks
by Tracey Ryniec
Big winner stocks are elusive but if you can find one, it can transform your portfolio.
4 Cosmetics Stocks Worth Watching on Robust Industry Trends
by Vrishali Bagree
The Zacks Cosmetics industry benefits from increased makeup and skincare demand. Also, focus on innovation and product launches is aiding Estee Lauder (EL), Coty (COTY), Helen of Troy (HELE) and Inter Parfums (IPAR).
The Estee Lauder Companies (EL) Beats on Earnings in Q2
by Zacks Equity Research
The Estee Lauder Companies' (EL) second-quarter fiscal 2022 sales and earnings rise year over year on growth in every region and product category. Management raises fiscal 2022 view.